To Replicate or Not to Replicate: The Case of Pharmacogenetic Studies
- 1 August 2013
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Genetics
- Vol. 6 (4) , 409-412
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- An integrated encyclopedia of DNA elements in the human genomeNature, 2012
- Effect of ACE insertion/deletion and 12 other polymorphisms on clinical outcomes and response to treatment in the life studyPharmacogenetics and Genomics, 2010
- Drug-Sensitized Zebrafish Screen Identifies Multiple Genes, Including GINS3 , as Regulators of Myocardial RepolarizationCirculation, 2009
- Gene and pathway-based second-wave analysis of genome-wide association studiesEuropean Journal of Human Genetics, 2009
- Comprehensive Whole-Genome and Candidate Gene Analysis for Response to Statin Therapy in the Treating to New Targets (TNT) CohortCirculation: Cardiovascular Genetics, 2009
- SLCO1B1Variants and Statin-Induced Myopathy — A Genomewide StudyNew England Journal of Medicine, 2008
- Neither Replication nor Simulation Supports a Role for the Axon Guidance Pathway in the Genetics of Parkinson's DiseasePLOS ONE, 2008
- Beyond Parkinson Disease: Amyotrophic Lateral Sclerosis and the Axon Guidance PathwayPLOS ONE, 2008
- Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studiesNature Genetics, 2006
- Replication in genetic studies of complex traitsAnnals of Human Genetics, 2004